Coexpression of androgen receptor and FOXA1 in nonmetastatic triple-negative breast cancer: ancillary study from PACS08 trial.
about
Epithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico InvestigationEstrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.Effects of Chinese medicinal herbs on expression of brain-derived Neurotrophic factor (BDNF) and its interaction with human breast cancer MDA-MB-231 cells and endothelial HUVECsAndrogen receptor expression on circulating tumor cells in metastatic breast cancer.Lack of both androgen receptor and forkhead box A1 (FOXA1) expression is a poor prognostic factor in estrogen receptor-positive breast cancers.Identification of Key Genes and Pathways in Triple-Negative Breast Cancer by Integrated Bioinformatics Analysis
P2860
Coexpression of androgen receptor and FOXA1 in nonmetastatic triple-negative breast cancer: ancillary study from PACS08 trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Coexpression of androgen recep ...... llary study from PACS08 trial.
@en
type
label
Coexpression of androgen recep ...... llary study from PACS08 trial.
@en
prefLabel
Coexpression of androgen recep ...... llary study from PACS08 trial.
@en
P2093
P2860
P356
P1433
P1476
Coexpression of androgen recep ...... llary study from PACS08 trial.
@en
P2093
Christel Mesleard
Céline Charon-Barra
Déwi Vernerey
Henri Roché
Jérôme Lemonnier
Laurent Arnould
Magali Lacroix-Triki
Marc Spielmann
Mario Campone
Pierre Fumoleau
P2860
P304
P356
10.2217/FON.15.102
P407
P577
2015-08-01T00:00:00Z